# Philips CPAP recall litigation

> Educational mass tort overview from DrugsMonitor.com. Not legal or medical advice.

**Canonical URL:** https://drugsmonitor.com/case/philips-cpap-recall-lawsuit
**Last updated:** 2026-06-11

## Key facts

- **Matter:** Philips CPAP Device
- **Status:** Discovery Phase
- **Scope:** United States — national overview
- **Drug safety page:** https://drugsmonitor.com/drug-info/philips-cpap-recall-lawsuit

## Overview

Philips recalled millions of CPAP, BiPAP, and ventilator devices after degraded polyester-polyurethane (PE-PUR) sound-abatement foam could release particles or volatile chemicals. Users allege respiratory injury, cancer, and other harms.

### Recall background

FDA classified the recall as Class I for many units—the most serious level—citing potential toxic and carcinogenic effects from foam breakdown, especially with ozone cleaning or high heat/humidity storage.

Plaintiffs assert design defect, failure to warn, and negligence; defendants dispute injury causation and exposure levels.

### MDL progress

The Western District of Pennsylvania hosts hundreds of cases with shared discovery into materials science, emissions testing, and company knowledge timelines.

Some claims may face statute-of-limitations defenses tied to recall notice dates, making prompt legal consultation material.

---

*DrugsMonitor.com is not a law firm. For medical decisions consult a licensed clinician; for legal decisions consult a qualified attorney.*